327 related articles for article (PubMed ID: 1704847)
1. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
2. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
[TBL] [Abstract][Full Text] [Related]
3. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
4. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U
Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197
[TBL] [Abstract][Full Text] [Related]
6. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
Herrera-Marschitz M; Christensson-Nylander I; Sharp T; Staines W; Reid M; Hökfelt T; Terenius L; Ungerstedt U
Exp Brain Res; 1986; 64(1):193-207. PubMed ID: 2429859
[TBL] [Abstract][Full Text] [Related]
7. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
[TBL] [Abstract][Full Text] [Related]
8. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
Reid MS; Herrera-Marschitz M; Ungerstedt U
Neuroscience; 1990; 36(3):659-67. PubMed ID: 1700330
[TBL] [Abstract][Full Text] [Related]
9. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
Reid MS; Herrera-Marschitz M; Ungerstedt U
J Neurochem; 1991 Sep; 57(3):970-4. PubMed ID: 1713616
[TBL] [Abstract][Full Text] [Related]
10. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
Reid MS; Herrera-Marschitz M; Kehr J; Ungerstedt U
Acta Physiol Scand; 1990 Dec; 140(4):527-37. PubMed ID: 1707211
[TBL] [Abstract][Full Text] [Related]
11. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
[TBL] [Abstract][Full Text] [Related]
12. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A
Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187
[TBL] [Abstract][Full Text] [Related]
13. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
You ZB; Nylander I; Herrera-Marschitz M; O'Connor WT; Goiny M; Terenius L
Neuroscience; 1994 Nov; 63(2):415-25. PubMed ID: 7891855
[TBL] [Abstract][Full Text] [Related]
14. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
[TBL] [Abstract][Full Text] [Related]
15. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
Tan DP; Tsou K
Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
[TBL] [Abstract][Full Text] [Related]
16. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
17. Characterization of GABA release from intrastriatal striatal transplants: dependence on host-derived afferents.
Campbell K; Kalén P; Wictorin K; Lundberg C; Mandel RJ; Björklund A
Neuroscience; 1993 Mar; 53(2):403-15. PubMed ID: 8098510
[TBL] [Abstract][Full Text] [Related]
18. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
[TBL] [Abstract][Full Text] [Related]
19. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
[TBL] [Abstract][Full Text] [Related]
20. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
Gerfen CR; McGinty JF; Young WS
J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]